<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04980079</url>
  </required_header>
  <id_info>
    <org_study_id>calculus anuria in children</org_study_id>
    <nct_id>NCT04980079</nct_id>
  </id_info>
  <brief_title>Primary Versus Deferred Ureteroscopy for Calculus Anuria in Children</brief_title>
  <official_title>Primary Versus Deferred Ureteroscopy for Management of Calculus Anuria in Children: A Prospective Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>South Valley University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>South Valley University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the role of both primary and deferred URS in the management of calculus anuria&#xD;
      concerning the feasibility, clinical outcome, and cost-effectiveness in children in a&#xD;
      comparative study&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Thirty group B (30) patients will be admitted to do urinary drainage through the insertion of&#xD;
      a JJ stent or percutaneous nephrostomy (PCN) at first , then a deferred URS will be done&#xD;
      children will undergo primary URS( group A ) and in. Ureteral dilatation will be done when&#xD;
      the stone size exceeds 10 mm to facilitate the extraction of the fragments. Ureteroscopic&#xD;
      lithotripsy will be done using a 6.5:7.5 Fr semi-rigid ureteroscope and holmium laser. The&#xD;
      ureteric stent will last for one week after lithotripsy. Postoperatively, the patients in&#xD;
      both groups will monitored for post obstructive diuresis, fever, hematuria, and extent of&#xD;
      renal function improvement.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>renal function</measure>
    <time_frame>one month .</time_frame>
    <description>improvement in creatinine level mg/dl urea level mg/dl</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the stone-free rates</measure>
    <time_frame>one month</time_frame>
    <description>The clinical outcomes of the procedures including the perioperative complications :&#xD;
of perforation&#xD;
of infection&#xD;
of residual stones&#xD;
of the stone-free rates</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Ureter Obstruction</condition>
  <arm_group>
    <arm_group_label>group A -undergo primary ureteroscopy URS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Thirty children with calicular anuria will undergo primary ureteroscopy URS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>the group B(30 patients) will undergo deferred ureteroscopy URS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>group B (30) patients will be admitted to do urinary drainage through the insertion of a double-J stent or percutaneous nephrostomy (PCN) at first , then a deferred ureteroscopy URS will be done</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Primary ureterscopy URS</intervention_name>
    <description>Ureteral dilatation will be done when the stone size exceeds 10 mm to facilitate the extraction of the fragments. Ureteroscopic lithotripsy will be done using a 6.5:7.5 Fr semi-rigid ureteroscope and holmium laser. The ureteric stent will last for one week after lithotripsy</description>
    <arm_group_label>group A -undergo primary ureteroscopy URS</arm_group_label>
    <other_name>URSureteroscopy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>deferred ureteroscopy URS</intervention_name>
    <description>insertion of a double -J stent or percutaneous nephrostomy (PCN) at first , then a deferred ureteroscopy URS will be done .</description>
    <arm_group_label>the group B(30 patients) will undergo deferred ureteroscopy URS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Children ˂12 years with calculus anuria.&#xD;
&#xD;
          -  Clinically stable (serum creatinine &lt; 3.5 mg/dl, blood urea &lt; 100 mg/dl,serum&#xD;
             potassium level &lt; 7 milliequivalent /L and /or ph of blood &gt; 7.1)&#xD;
&#xD;
          -  All the patients free of sepsis.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unstable children (serum creatinine ≥ 3.5 mg/dl, blood urea ≥ 100 mg/dl, serum&#xD;
             potassium ≥ 7 milliequivalent/l, and/or blood pH ≤ 7.1, signs of acidosis, sepsis, or&#xD;
             fluid retention).&#xD;
&#xD;
          -  Children with underlying urological structural abnormalities&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mostafa abdelrazek, MD</last_name>
    <role>Study Director</role>
    <affiliation>SVU</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>mostafa mostafa, B.sc</last_name>
    <phone>01069432827</phone>
    <email>mostafaalsoghier@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mostafa</name>
      <address>
        <city>Luxor</city>
        <zip>85951</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mostafa Mostafa, B.sc</last_name>
      <phone>01069432827</phone>
      <email>mostafaalsoghier@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>asmaa mostafa, MD</last_name>
      <phone>010144437474</phone>
      <email>lalamohamed@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 14, 2021</study_first_submitted>
  <study_first_submitted_qc>July 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 28, 2021</study_first_posted>
  <last_update_submitted>July 17, 2021</last_update_submitted>
  <last_update_submitted_qc>July 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>South Valley University</investigator_affiliation>
    <investigator_full_name>Mostafa Mohamed Mostafa</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ureteral Obstruction</mesh_term>
    <mesh_term>Calculi</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

